Propath Receives Queen’s Award for Enterprise

News   Apr 26, 2017 | Original story from Propath

 
Propath Receives Queen’s Award for Enterprise
 
 
 
 

RELATED ARTICLES

Biological Fingerprint of Tuberculosis Meningitis Discovered in Children

News

Children with tuberculosis meningitis have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments.

READ MORE

HIV Envelope Trimer Immunization Approach Optimized

News

Optimized immunizations reliably elicit protective antibodies in preclinical study, marking an important milestone on the way to an effective HIV vaccine.

READ MORE

BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-Oncology

News

QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE